During the three-year shortage period, Hims & Hers, along with many other companies, began selling a compounded version of the drug, capturing profits that would be typically foreclosed by competitor Novo Nordisks patents
Hypertension, type 2 diabetes, dyslipidemia (high cholesterol), obstructive sleep apnea, and cardiovascular disease are the most commonly accepted comorbidities
The SUSTAIN-6 cardiovascular outcome trial, with approximately 2.1 years of follow-up, and the SELECT trial, with over 3 years of follow-up, have not identified safety signals for thyroid malignancy
The effect of carnitine supplementation in valproate-induced hyperammonaemia
This dose provides mild appetite suppression, improves blood sugar control, and reduces gastric emptying, but the effect is significantly less than that of standard therapeutic doses